Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G/A
Neuronetics, Inc.
10 Feb 21
SC 13G/A
Principia Biopharma Inc.
13 Feb 20
SC 13G/A
Neuronetics, Inc.
13 Feb 20
4
Leaf Venture Management II, L.L.C. New
15 Aug 19
SC 13G
Principia Biopharma Inc.
13 Feb 19
SC 13G
Neuronetics, Inc.
13 Feb 19
4
Leaf Venture Management II, L.L.C. New
20 Sep 18
3
Leaf Venture Management II, L.L.C. New
13 Sep 18
4
Leaf Venture Management II, L.L.C. New
5 Jul 18
3
Leaf Venture Management II, L.L.C. New
27 Jun 18
SC 13G/A
Oxford Immunotec Global PLC
21 Aug 17
SC 13G/A
iRhythm Technologies, Inc.
6 Jul 17
SC 13D/A
Versartis, Inc.
28 Mar 17
SC 13G
iRhythm Technologies, Inc.
10 Feb 17
SC 13D/A
Versartis, Inc.
14 Nov 16
4
RONALD HUNT
25 Oct 16
3
Philippe O. Chambon
19 Oct 16
SC 13D/A
Versartis, Inc.
14 Apr 15
SC 13D/A
MEI Pharma, Inc.
31 Mar 15
4
Liam Ratcliffe
26 Mar 15
SC 13G/A
CHIMERIX INC
17 Feb 15
SC 13D/A
Durata Therapeutics, Inc.
19 Nov 14
SC 13D/A
Versartis, Inc.
14 Nov 14
SC 13D
Versartis, Inc.
7 Apr 14
SC 13G
CHIMERIX INC
14 Feb 14
SC 13G
Oxford Immunotec Global PLC
14 Feb 14
SC 13G/A
AMBIT BIOSCIENCES CORP
27 Dec 13
SC 13D/A
MEI Pharma, Inc.
27 Nov 13
SC 13D/A
MEI Pharma, Inc.
6 Nov 13
SC 13G
AMBIT BIOSCIENCES CORP
24 May 13
SC 13D/A
MEI Pharma, Inc.
15 May 13
SC 13D/A
MEI Pharma, Inc.
1 Mar 13
SC 13D
MEI Pharma, Inc.
10 Dec 12
SC 13D/A
WORLD HEART CORP
13 Aug 12
SC 13D
Durata Therapeutics, Inc.
1 Aug 12
SC 13D/A
SYNAGEVA BIOPHARMA CORP
9 Jul 12
SC 13D/A
SYNAGEVA BIOPHARMA CORP
28 Mar 12
SC 13D
SYNAGEVA BIOPHARMA CORP
14 Nov 11
SC 13D/A
ICAGEN INC
25 Aug 11
SC 13D/A
ICAGEN INC
11 Aug 11